Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (UNAUDITED)

v3.20.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
Series A Preferred Stock
Series B Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning Balance, Shares at Dec. 31, 2018 185 52 134,793,211      
Beginning Balance, Amount at Dec. 31, 2018 $ 1,340,566 $ 362,059 $ 134,792 $ 127,570,709 $ (123,171,406) $ 6,236,720
Shares issued directors, shares 292,308      
Shares issued to directors, value $ 294 35,708 36,002
Stock-based compensation expense related to employee stock options 1,815 1,815
Net loss attributable to common stockholders (845,604) (845,604)
Ending Balance, Shares at Mar. 31, 2019 185 52 135,085,519      
Ending Balance, Amount at Mar. 31, 2019 $ 1,340,566 $ 362,059 $ 135,086 127,608,232 (124,017,010) 5,428,933
Shares issued directors, shares 246,432      
Shares issued to directors, value $ 245 35,753 35,998
Stock-based compensation expense related to employee stock options 1,816 1,816
Net loss attributable to common stockholders (518,575) (518,575)
Ending Balance, Shares at Jun. 30, 2019 185 52 135,331,951      
Ending Balance, Amount at Jun. 30, 2019 $ 1,340,566 $ 362,059 $ 135,331 127,645,801 (124,535,585) 4,948,172
Shares issued directors, shares 301,399      
Shares issued to directors, value $ 301 32,699 33,000
Stock-based compensation expense related to employee stock options 1,815 1,815
Net loss attributable to common stockholders (753,869) (753,869)
Ending Balance, Shares at Sep. 30, 2019 185 52 135,633,350      
Ending Balance, Amount at Sep. 30, 2019 $ 1,340,566 $ 362,059 $ 135,632 127,680,315 (125,289,454) 4,229,118
Beginning Balance, Shares at Dec. 31, 2019 185 52 135,990,491      
Beginning Balance, Amount at Dec. 31, 2019 $ 1,340,566 $ 362,059 $ 135,990 127,708,773 (125,105,539) 4,441,849
Shares issued directors, shares 320,844      
Shares issued to directors, value $ 321 17,679 18,000
Stock-based compensation expense related to employee stock options 1,815 1,815
Net loss attributable to common stockholders (652,501) (652,501)
Ending Balance, Shares at Mar. 31, 2020 185 52 136,311,335      
Ending Balance, Amount at Mar. 31, 2020 $ 1,340,566 $ 362,059 $ 136,311 127,728,267 (125,758,040) 3,809,163
Shares issued directors, shares      
Shares issued to directors, value
Stock-based compensation expense related to employee stock options 1,816 1,816
Net loss attributable to common stockholders (950,097) (950,097)
Ending Balance, Shares at Jun. 30, 2020 185 52 136,311,335      
Ending Balance, Amount at Jun. 30, 2020 $ 1,340,566 $ 362,059 $ 136,311 127,730,083 (126,708,137) 2,860,882
Shares issued directors, shares      
Shares issued to directors, value
Stock-based compensation expense related to employee stock options 1,815 1,815
Net loss attributable to common stockholders (676,755) (676,755)
Ending Balance, Shares at Sep. 30, 2020 185 52 136,311,335      
Ending Balance, Amount at Sep. 30, 2020 $ 1,340,566 $ 362,059 $ 136,311 $ 127,731,898 $ (127,384,892) $ 2,185,942